Table 2 Rhinitis in asthma: guidelines
Guideline | Author, year | Chapter | Diagnostic or therapeutic considerations |
|---|---|---|---|
GEMA 4.0 [7], Spanish Guideline on the Management of Asthma | Executive Committee of the GEMA, 2015 | 6. Rhinitis and nasal polyposis | Treatment of rhinitis is indicated in the treatment of asthma Inter-relationships between treatments (anti-leukotrienes, intranasal corticosteroids, immunotherapy) and epidemiological aspects are addressed |
GINA 2016, Global Strategy for Asthma Management and Prevention [8] | 2016 GINA Report | Part D. Managing asthma with comorbidities and in special populations Rhinitis, sinusitis and nasal polyps | Refers to ARIA |
British guideline on the Management of Asthma [9] | British Thoracic Society, 2014 | No | Studies confirm that atopic dermatitis and atopic rhinitis are amongst the factors most strongly associated with asthma persisting into teenage years |
NAEPP [10], National Asthma Education and Prevention Program | Expert Panel Report 3, 2007 | Section 3, Component 3: Control of Environmental Factors and Comorbid Conditions That Affect Asthma Comorbid conditions Rhinitis/sinusitis | It is important for clinicians to appreciate the association between upper and lower airway conditions and the part this association plays in asthma management |